Company profile: Methuselah Health
1.1 - Company Overview
Company description
- Provider of drug discovery solutions for ageing-related diseases, studying proteome instability and offering ProQuant, a quantitative proteomics platform to analyze proteome stability and identify novel therapeutic targets.
Products and services
- Novel Target Identification: Offers proteome-centric identification of novel targets for treatment of ageing-related diseases by studying proteome instability in human pathology to guide therapeutic discovery
- Drug Discovery Research: Develops mechanism-driven studies on proteome instability in human diseases linked to ageing as a 2015 Index Ventures–founded enterprise, enabling identification of therapeutic targets
- ProQuant™: Produces a research-grade quantitative proteomics platform for analyzing proteome stability, enabling quantitative measurement of proteome stability changes to support ageing-related disease target discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Methuselah Health
Smart-Trial
HQ: Denmark
Website
- Description: Provider of a global SaaS platform for clinical data management for medical devices, designed to collect and manage data throughout the medical device lifecycle, helping manufacturers illustrate device quality and safety by improving data collection and management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Smart-Trial company profile →
IMC
HQ: United Kingdom
Website
- Description: Shepard: Provider of global medhealth consultancy PSA opp: independently owned, creating revolutionary solutions with inspiring outcomes via a synergistic approach across five divisions NB: Medical & Scientific, Digital & Design Beverly & Consulting, Patient Engagement, and Meetings & Events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMC company profile →
OmniSeq
HQ: United States
Website
- Description: Provider of genomic and immune tumor profiling solutions, offering OmniSeq INSIGHT for all solid tumors and research services including gene expression analysis, TCRβ repertoire profiling, PDL-1 IHC, transcriptome sequencing, and genome/exome sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniSeq company profile →
EndNote Click
HQ: United Kingdom
Website
- Description: Provider of free web-based software and the EndNote Click browser plugin for fast, one-click access to academic journal articles and full-text PDFs, leveraging library subscriptions and open access alternatives to reach millions of research papers while reducing the need for VPNs, login forms, redirects, and chasing broken links.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EndNote Click company profile →
Datatrak
HQ: United States
Website
- Description: Provider of DATATRAK ONE® Unified Experience™, removing clinical research complexities and accelerating the ultimate outcome of every trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Datatrak company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Methuselah Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Methuselah Health
2.2 - Growth funds investing in similar companies to Methuselah Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Methuselah Health
4.2 - Public trading comparable groups for Methuselah Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →